← Issue №3/ week of Jul 19, 2026/ the whole section, in full

Colorectal, in full.

All 1 Colorectal paper in this issue, as full cards, ranked by clinical utility. The issue page carries the strongest few; this is the section, whole.

Sections this issue
Filter

All 1, in full

most clinically useful first
Colorectal rct · n=102 · Jul 21, 2026 · Dis Colon Rectum · IF 3.5

Five-Year Follow-up of the Double-Blind Randomized Controlled Trial Comparing Laser Hemorrhoidoplasty With Sutured Mucopexy and Excisional Hemorrhoidectomy.

New evidencecolorectal surgery
Clinical takeawayFor symptomatic grade 2-3 hemorrhoids requiring surgery, counsel patients on a two-option framework: excisional hemorrhoidectomy for maximum long-term durability (24% recurrence) if the patient tolerates longer recovery, or laser hemorrhoidoplasty for nearly equivalent recurrence control (29%) with notably better quality-of-life scores and a significantly shorter and less painful postoperative course. The choice should hinge on patient priority-durable symptom control versus rapid functional recovery-rather than recurrence rates alone, as the 5% absolute difference is not statistically significant at 5 years. Sutured mucopexy shows the worst long-term recurrence (44%) and should be reserved for highly selected cases.
What it foundFive-year symptom recurrence: excisional hemorrhoidectomy 24%, laser hemorrhoidoplasty 29%, sutured mucopexy 44% (differences not statistically significant, p=0.076); excisional hemorrhoidectomy had the lowest bleeding recurrence (18% vs 31% for both LH and SM) and prolapse (12% vs 23% for LH and 34% for SM); laser hemorrhoidoplasty group reported the highest general health evaluation scores.
ContextConfirms excisional hemorrhoidectomy as the most durable surgical option while validating laser hemorrhoidoplasty as a clinically equivalent alternative on recurrence; shifts the focus from efficacy alone to patient-centered shared decision-making on postoperative quality of life and recovery speed.
Measured against the standard of care· ASCRS 2024 (Dis Colon Rectum 2024;67(5):614-623) / AGA Clinical Practice Update 2026 (Clin Gastroenterol Hepatol, Qureshi et al.)

Decision at stakechoice of surgical approach (excisional hemorrhoidectomy vs. laser hemorrhoidoplasty) for refractory grade III hemorrhoids

… Refer grade III disease refractory to office procedures, grade IV disease, and symptomatic combined internal/external disease for excisional hemorrhoidectomy, the definitive treatment. …

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

Two current US documents now apply: ASCRS 2024 (GRADE-graded clinical practice guideline) and the AGA 2026 Clinical Practice Update (expert review, 11 best practice advice statements, no GRADE strength; Qureshi, Hoang, Frye, Rao; Clin Gastroenterol Hepatol, online April 29, 2026). Diagnosis: take a disease-specific history and exam. AGA advises anoscopy, whenever possible, for every new patient with suspected hemorrhoids before any treatment, to confirm the diagnosis and exclude other pathology including cancer. Do not automatically attribute rectal bleeding to hemorrhoids. Complete colonic evaluation is for select patients: no obvious anorectal bleeding source, associated abdominal symptoms or change in bowel habit, persistent hematochezia after successful treatment, or due for CRC screening. Grade internal hemorrhoids I-IV by prolapse. First line is diet and behavior: fiber (AGA cites 20-30 g/day) plus fluid, avoid straining, and limit toilet time (AGA cites about 3 minutes). Sitz baths have little evidence. Topical anesthetics, corticosteroids and vasoactive agents may give short-term relief on weak evidence; AGA limits topical corticosteroids to 2 weeks or less because of skin atrophy. ASCRS adds that oral phlebotonics help bleeding, pruritus and discharge but not pain. Office procedures come before surgery for grade I-III disease (ASCRS: grade I-II and select grade III refractory to conservative care). Rubber band ligation is the most effective office procedure (AGA: 66-94% success, more durable for prolapse and recurrent bleeding; about 2% complications). Infrared coagulation is comparable in the short term and preferred in anticoagulated patients, patients with coagulopathy or cirrhosis, and pregnant patients. Counsel every procedural patient on the rare risk of pelvic sepsis and its warning signs. Refer grade III disease refractory to office procedures, grade IV disease, and symptomatic combined internal/external disease for excisional hemorrhoidectomy, the definitive treatment. Doppler-guided artery ligation is an option (less pain, more recurrence). Stapled hemorrhoidopexy is not routinely first line (higher recurrence, unique serious complications). Special populations (AGA): in active Crohn's disease or UC, defer hemorrhoid treatment until remission; in pregnancy, treat conservatively and defer procedures until after delivery unless necessary; in cirrhosis, distinguish hemorrhoids from rectal varices. Acutely thrombosed external hemorrhoids: the two societies differ. ASCRS 2024 says select patients may benefit from early surgical excision, which beats incision/evacuation for recurrence. AGA 2026 says these are best treated surgically by incision and drainage, which relieves symptoms faster than nonoperative care (a secondary summary places this within 72 hours).

ASCRS 2024 (Dis Colon Rectum 2024;67(5):614-623) / AGA Clinical Practice Update 2026 (Clin Gastroenterol Hepatol, Qureshi et al.) · reviewed 2026-10-11 ↗
Makunaite G … Poskus T · Diseases of the Colon and Rectum · IF 3.5 · PubMed ↗Permalink
← Back to issue №3 Every section of this issue is one click away, at the top of this page. Follow Colorectal by RSS